Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
When Stevie Jones opted for NuvaRing as her birth control of choice, she had no idea that the seemingly innocent plastic ring was linked to blood clots, deep vein thrombosis (DVT) and pulmonary embolism injuries. However, she joined the many other women who learned about these risks the hard way and sued the manufacturer of NuvaRing on Oct. 29, 2013. According to her NuvaRing lawsuit, Jones “suffered from a blood clot to the brain” on Oct. 3, 2010.
Jones says that the drug manufacturer marketed NuvaRing as the “first and only, once-a-month vaginal birth control ring.” According to the NuvaRing lawsuit, the contraceptive ring was also advertised as “providing the same efficacy as birth control pills or the patch in preventing pregnancy, but with more convenience” because women do not have to remember to take a daily pill. Jones argues that the defendants failed to adequately warn about the health risks associated with NuvaRing.
“The package insert accompanying NuvaRing stated that the vaginal ring is expected to be associated with similar risks to that of birth control pills and that the safety information they provide to consumers is derived primarily from studies of birth control pills. Therefore, the safety information provided to the consumer was not derived primarily from studies of NuvaRing and, therefore, the package insert accompanying NuvaRing is misleading,” notes her NuvaRing lawsuit.
“Defendants failed to warn of the extent of the risk of stroke, venous thromboembolism, including Superficial Venous Thrombosis (SVT), Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), stroke, and death” associated with the NuvaRing.Jones says that had she known of the actual risks of NuvaRing complications, she could have taken precautions or not opted for the device at all. She also states that Merck “negligently and/or recklessly marketed the NuvaRing as a novel vaginal delivery system, and placed the product into the stream of commerce without conducting adequate tests to regulate the exposure and/or release rates of estrogen and Progestin to a user, including Plaintiff, of such product.”
Jones is suing the drug makers for defective manufacturing, defective design, defect due to inadequate warning, breach of warranty, negligence, misrepresentation and fraud, violation of Utah consumer protection acts, and successor liability.
The NuvaRing lawsuit is Stevie Jones v. Organon USA Inc., et al., Case No. 0:13-cv-02960-RHK-JJK, in the U.S. District Court for the District of Minnesota.
Were You Harmed by NuvaRing Complications?
If you took NuvaRing after Jan. 1, 2011, and suffered deep vein thrombosis or pulmonary embolism, you may qualify for compensation. Learn more about steps you can take by visiting the NuvaRing Birth Control Class Action Lawsuit Settlement & Investigation. Once you submit your story, a lawyer will reach out to you if you have a case for a free NuvaRing claim review.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
